Our data support this notion, given that dysregulated CD8+ T cell responses were associated with intense tumor IFN-I and an absence of key type 2 inflammatory cells, namely, TAMs (which predominantly exhibited an M2 phenotype), fibroblasts, and ILC2s. The gene discussed is CD8A; the disease is neoplasm.